ArticleClinical and translational medicine2024

A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma.

Vincent M DeStefano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.